← Browse by Condition
Medical Condition
t acute lymphoblastic leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT07021677 Phase 2
Recruiting
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
Enrollment
18 pts
Location
India
Sponsor
Tata Memorial Centre
NCT05602194 Phase 3
Recruiting
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Enrollment
440 pts
Location
United States, Canad...
Sponsor
Children's Oncology Group